Charles Allan
Chief Executive Officer
EMAIL CONNECT
charles.allan@my01.io LinkedIn
Charles Allan is passionate about using really small things to solve big problems. Being surrounded by many successful and supportive entrepreneurs, he quickly gained an ability to create teams and transform problems into solutions.
An example of his passion at work can be found during his undergraduate years at Queens University, where he helped build a microfluidic pump for an implantable therapeutic for glaucoma. This project helped ignite his entrepreneurial spirit, and, while pursuing his Masters in Bioelectrical Engineering at McGill University, he formed a team that combined engineering and technology to develop microsolutions. Some of those initial microsystems are the foundational components used by the three companies that Charles founded: MY01, Inc., Stathera, Inc., and NXTSENS Microsystems, Inc. These companies each have won several awards and been selected for important growth accelerators. They have grown to over 70 employees, and combined to raise over $50M in funding.
Ed Harvey
Chief Medical Officer
EMAIL CONNECT
Dr. Edward J. Harvey has a rich history of collaboration with basic, clinical and engineering scientists. He is a tenured Professor of Surgery at McGill University. He is the trauma research program leader at the Research Institute of the McGill University Health Centre (RI-MUHC) with over 60 investigators in his group. He is, or has been, editor-in-chief of the Canadian Journal of Surgery; editorial board member of the Journal of Orthopaedic Trauma and OTA International; chairman of the Research Committee and the Annual meeting program chair for the Orthopedic Trauma Association; chair of the Trauma Section at the Orthopaedic Research Society; and president of the Canadian Orthopaedic Association amongst other national and international positions.
George Xereas
Chief Technology Officer
EMAIL CONNECT
george.xereas@my01.io LinkedIn
George Xereas is the Chief Technology Officer at MY01 Inc. In this role, he leads the company’s technology and product development. Prior to MY01 Inc., he served as the Chief Technology Officer for NXTSENS Microsystems Inc., a fabless MEMS based sensor company he co-founded. George obtained his PhD in Electrical and Electronics Engineering from McGill University in 2017, which was supported by the Les Vadasz Doctoral Fellowship in Engineering – Intel. George is an author in 19 high impact publications in MEMS sensors, and is an inventor in 14 utility patents.
Olivier Bataille
Chief Operations Officer
EMAIL CONNECT
olivier.bataille@my01.io LinkedIn
Olivier Bataille is a seasoned professional with 25 years of experience in the medical device industry. Olivier was the Vice President of Product Development and Operations at CryoCath Medtronic, Inc. Joining CryoCath in 2005 as the Vice President of Product Development with foreign expert status, Olivier led significant achievements including the release of new robust and reliable systems and devices. As a member of the executive management team, Olivier played a key role in the sale of CryoCath Technologies Inc. to Medtronic Inc. for more than 10 times revenue. Olivier holds a Baccalaureate in Mathematics and Technology, and is a mechanical engineer from Northeastern University in Boston, Massachusetts.
Jay Merkel
Chief Commercial Officer
EMAIL CONNECT
Jay Merkel joins MY01 with over 20 years of experience in the medical device industry. Jay was most recently the Global Franchise Leader at Integra Life Sciences where she was responsible for the global wound reconstruction business. She joined Integra as part of the acquisition of ACell, Inc. where she was the General Manager, Global Surgical and Cardiac. Prior to this role at ACell, Jay had responsibility as the Sr. Director of Marketing focused on downstream marketing activities, communications, market access, and reimbursement. Previously, Jay held marketing leadership positions at Becton Dickinson, Carefusion, Olympus, and B. Braun. Jay holds a M.B.A from Lehigh University and a Bachelor of Science in Mechanical Engineering from Case Western Reserve University.
Gino Lambo
Director of Sales
EMAIL CONNECT
Gino Lambo brings over 25 years of Sales Leadership to MY01. Over the years, he has displayed a record of developing high-performing teams through robust training initiatives while also cultivating strong client relationships across the entire sales cycle. He has extensive experience with market leaders such as Stryker, Johnson & Johnson, Halyard Health, and Celularity as well as with smaller start-ups like Alliqua and most recently, MolecuLight. His tenure has equipped him with skills to execute comprehensive sales strategies aimed at identifying new opportunities to build a foundation for long-term success. Gino has a Bachelor of Arts degree from the University of St. Thomas – Minnesota.
Simon Sanscartier
VP Europe and Emerging Markets
EMAIL CONNECT
simon.sanscartier@my01.io LinkedIn
Simon Sanscartier started his career working in corporate finance for a public company and then an institutional bank. He founded two Software as a Service companies, the most recent one exiting in 2016. He joined MY01 while it was still located in the lab at McGill University and quickly became involved in all aspects of the company: serving as CFO, driving change within the company, completing year-end audits, performing HR duties, raising capital, and developing significant relationships within the industry. As the company evolved, Simon’s role became focused on fundraising and market development in Canada and Europe. Simon holds a CPA in Accounting and Finance from Université de Sherbrooke.
Dr. Edward J. Harvey has a rich history of collaboration with basic, clinical and engineering scientists. He is a tenured Professor of Surgery at McGill University. He is the trauma research program leader at the Research Institute of the McGill University Health Centre (RI-MUHC) with over 60 investigators in his group. He is, or has been, editor-in-chief of the Canadian Journal of Surgery; editorial board member of the Journal of Orthopaedic Trauma and OTA International; chairman of the Research Committee and the Annual meeting program chair for the Orthopedic Trauma Association; chair of the Trauma Section at the Orthopaedic Research Society; and president of the Canadian Orthopaedic Association amongst other national and international positions.
Charles Allan is passionate about using really small things to solve big problems. Being surrounded by many successful and supportive entrepreneurs, he quickly gained an ability to create teams and transform problems into solutions.
An example of his passion at work can be found during his undergraduate years at Queens University, where he helped build a microfluidic pump for an implantable therapeutic for glaucoma. This project helped ignite his entrepreneurial spirit, and, while pursuing his Masters in Bioelectrical Engineering at McGill University, he formed a team that combined engineering and technology to develop microsolutions. Some of those initial microsystems are the foundational components used by the three companies that Charles founded: MY01, Inc., Stathera, Inc., and NXTSENS Microsystems, Inc. These companies each have won several awards and been selected for important growth accelerators. They have grown to over 70 employees, and combined to raise over $50M in funding.
George Xereas is the Chief Technology Officer at MY01 Inc. In this role, he leads the company’s technology and product development. Prior to MY01 Inc., he served as the Chief Technology Officer for NXTSENS Microsystems Inc., a fabless MEMS based sensor company he co-founded. George obtained his PhD in Electrical and Electronics Engineering from McGill University in 2017, which was supported by the Les Vadasz Doctoral Fellowship in Engineering – Intel. George is an author in 19 high impact publications in MEMS sensors, and is an inventor in 14 utility patents.